top of page

Scientific Presentations & Publications

SKY-0515

June 26, 2026

2026 Congress of the European Academy of Neurology (EAN)

Investigation of SKY-0515 in patients with Huntington's disease. This poster covers interim results of a Phase 1/2 study.

​

Screenshot 2026-06-29 at 6.04.22 AM.png
Small Molecules that Modify RNA Expression
Contact

Skyhawk Therapeutics, Inc.
180 3rd Ave., Sixth Floor
Waltham, MA 02451
United States

info@skyhawktx.com
1-617-858-0041

​

Skyhawk Therapeutics Europe, GmbH
Hochbergerstrasse 60I
Basel 4057 Switzerland
+41 (0) 61 512 15 20

​

​

​

  • Facebook
  • LinkedIn

©2026 Skyhawk Therapeutics - All Rights Reserved

Skyhawk, SkyStar and triangle mark are federally registered trademarks owned by Skyhawk Therapeutics, Inc.

bottom of page